open102 vuesGlobal
Quarterly Research Grant
Cure Parkinson's Quarterly Research Grant funds preclinical and clinical research aimed at slowing, stopping, or reversing Parkinson's disease. Research strictly focused on symptomatic relief is ineligible. The grant operates a two-stage application process: Stage 1 involves email submission of an application form, Drug/Compound CV, and optionally CVs, budgets, and supplementary data; Stage 2 is by invitation only, involving external peer review and trustee approval. The process takes approximately six months from submission to funding decision.
Qui peut postuler
Open internationally to both academic and commercial entities for disease-modifying Parkinson's research. Preclinical grants up to £250,000; clinical funding amounts are flexible. Research must aim to slow, stop, or reverse Parkinson's progression.Avantages et bénéfices
- Patient and Public Involvement and Engagement (PPIE) support available
- Collaboration with researchers, scientists, patients, and funders
- Access to Clinical Trials Charter standards
- Research Committee Internship opportunities for PhD students and post-docs
- 3P Seminars and research events access
Contacts clés
Sources
Liens utilisés par l'IA pour recueillir des informations sur cette subvention.